EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Medigen Biotechnology Corporation (3176) - Financial and Strategic SWOT Analysis Review

  • ID: 2051328
  • SWOT Analysis
  • July 2016
  • 33 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • DR. Chip Biotech Inc.
  • PhytoHealth Corporation
  • Vita Genomics, Inc.
  • MORE
Medigen Biotechnology Corporation (3176) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Medigen Biotechnology Corporation (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s product portfolio includes monoclonal antibodies; vaccines; molecular diagnostics and generic drugs. MBC also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) manufacturing services in various dosage forms including orals, externals, ophthalmic and hormones; nutrition supplements; cosmeceutical products. ’s subsidiaries include Medigen Vaccine Biologics; TBG Biotechnology Corp.; and Winston Medical Supply Co., Ltd. MBC is headquartered in Taipei city, Taiwan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • DR. Chip Biotech Inc.
  • PhytoHealth Corporation
  • Vita Genomics, Inc.
  • MORE
List of Tables

List of Figures

Section 1 - About the Company

Medigen Biotechnology Corporation - Key Facts

Medigen Biotechnology Corporation - Key Employees

Medigen Biotechnology Corporation - Key Employee Biographies

Medigen Biotechnology Corporation - Major Products and Services

Medigen Biotechnology Corporation - History

Medigen Biotechnology Corporation - Company Statement

Medigen Biotechnology Corporation - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Medigen Biotechnology Corporation - Business Description

Medigen Biotechnology Corporation - SWOT Analysis

SWOT Analysis - Overview

Medigen Biotechnology Corporation - Strengths

Strength - Core Technology Platform

Strength - Drug Development

Strength - Product Portfolio

Medigen Biotechnology Corporation - Weaknesses

Weakness - History of Operating Losses

Weakness - Project Discontinuation

Medigen Biotechnology Corporation - Opportunities

Opportunity - Pipeline Products

Opportunity - Market Potential: Oncology

Opportunity - Market Potential: Chinese Pharmaceutical Market

Medigen Biotechnology Corporation - Threats

Threat - Rapid Technological Changes

Threat - Competitive Atmosphere

Threat - Compliance with Government Regulations

Medigen Biotechnology Corporation - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Medigen Biotechnology Corporation, Recent Deals Summary

Section 5 – Appendix

Methodology

Ratio Definitions

About us

Contact Us

Disclaimer

List of Tables

Medigen Biotechnology Corporation, Key Facts

Medigen Biotechnology Corporation, Key Employees

Medigen Biotechnology Corporation, Key Employee Biographies

Medigen Biotechnology Corporation, Major Products and Services

Medigen Biotechnology Corporation, History

Medigen Biotechnology Corporation, Other Locations

Medigen Biotechnology Corporation, Subsidiaries

Medigen Biotechnology Corporation, Key Competitors

Medigen Biotechnology Corporation, Ratios based on current share price

Medigen Biotechnology Corporation, Annual Ratios

Medigen Biotechnology Corporation, Interim Ratios

Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Medigen Biotechnology Corporation, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Medigen Biotechnology Corporation, Performance Chart (2011 - 2015)

Medigen Biotechnology Corporation, Ratio Charts

Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Note: Product cover images may vary from those shown
3 of 4
Lumosa Therapeutics Co., Ltd.
Development Center for Biotechnology
Taiwan Liposome Company, Ltd.
Vita Genomics, Inc.
DR. Chip Biotech Inc.
PhytoHealth Corporation
Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll